Axial Biotech, Inc   Report issue

For profit Phase 2 Phase 3
Founded: Salt Lake City UT United States (2002)

Organization Overview

First Clinical Trial
2019
NCT03803007
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AIXIAL Development | Axial Biotech, Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

acetaminophen (tylenol) (1 trial)

Drugs in Phase 2 Trials (1)

act017 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 3)

Cerebral Infarction (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2